Human chorionic gonadotropin as a target for cancer vaccines.

  • Authors:
    • P L Triozzi
    • V C Stevens
  • View Affiliations

  • Published online on: January 1, 1999     https://doi.org/10.3892/or.6.1.7
  • Pages: 7-24
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Human chorionic gonadotropin (hCG) is expressed by common cancers and may play a role in cell transformation as well as angiogenic, metastatic, and immune escape phenomena that are central to cancer progression. Clinical trials with a vaccine targeting the carboxy-terminal peptide of -hCG have indicated that tolerance to this oncofetal antigen can be broken. Humoral responses that may modulate the biologic activity of tumor-associated hCG as well as cellular responses to hCG have been generated. Studies are in progress to further define the biologic significance of hCG in cancer and to develop a vaccine approach that will best target this expression.

Related Articles

Journal Cover

Jan-Feb 1999
Volume 6 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Triozzi P and Triozzi P: Human chorionic gonadotropin as a target for cancer vaccines.. Oncol Rep 6: 7-24, 1999
APA
Triozzi, P., & Triozzi, P. (1999). Human chorionic gonadotropin as a target for cancer vaccines.. Oncology Reports, 6, 7-24. https://doi.org/10.3892/or.6.1.7
MLA
Triozzi, P., Stevens, V."Human chorionic gonadotropin as a target for cancer vaccines.". Oncology Reports 6.1 (1999): 7-24.
Chicago
Triozzi, P., Stevens, V."Human chorionic gonadotropin as a target for cancer vaccines.". Oncology Reports 6, no. 1 (1999): 7-24. https://doi.org/10.3892/or.6.1.7